4.4 Article

Validation of sleep measurement in a multisensor consumer grade wearable device in healthy young adults

期刊

JOURNAL OF CLINICAL SLEEP MEDICINE
卷 16, 期 6, 页码 917-924

出版社

AMER ACAD SLEEP MEDICINE
DOI: 10.5664/jcsm.8362

关键词

actigraphy; consumer wearable; photoplethysmography; polysomnogrrahy; sleep tracker; validation

资金

  1. NIMH NIH HHS [K01 MH109871] Funding Source: Medline
  2. CSRD VA [IK2 CX002032] Funding Source: Medline

向作者/读者索取更多资源

Study Objectives: Our objective was to examine the ability of a consumer-grade wearable device (Basis B1) with accelerometer and heart rate technology to assess sleep patterns compared with polysomnography (PSG) and research-grade actigraphy in healthy adults. Methods: Eighteen adults underwent consecutive nights of sleep monitoring using Basis B1, actigraphy, and PSG; 40 nights were used in analyses. Discrepancies in gross sleep parameters and epoch-by-epoch agreements in sleep/wake classification were assessed. Results: Basis B1 accuracy was 54.20 +/- 8.20%, sensitivity was 98.90 +/- 2.70%, and specificity was 8.10 +/- 15.00%. Accuracy, sensitivity, and specificity for distinguishing between the different sleep stages were 60-72%, 48-62%, and 57-86%, respectively. Pearson correlations demonstrated strong associations between Basis B1 and PSG estimates of sleep onset latency and total sleep time; moderate associations for sleep efficiency, duration of light sleep, and duration of rapid eye movement sleep; and a weak association for duration of deep sleep. Basis B1 significantly overestimates total sleep time, sleep efficiency, and duration of light sleep and significantly underestimates wake after sleep onset and duration of deep sleep. Conclusions: Basis B1 demonstrated utility for estimates of gross sleep parameters and performed similarly to actigraphy for estimates of total sleep time. Basis B1 specificity was poor, and Basis B1 is not useful for the assessment of wake. Basis B1 accuracy for sleep stages was better than chance but is not a suitable replacement for PSG assessment. Despite low cost, ease of use, and attractiveness for patients, consumer devices are not yet accurate or reliable enough to guide treatment decision making in clinical settings.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据